Showing results (11-20 of 271) with videos related to
Sort By:
Pageof 28
Journal of Biological Regulators and Homeostatic Agents|November 24, 1999
Hydroxyurea in the treatment of HIV-1 infection: toxicity and side effectsR MaseratiJournal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitorsE Seminari, F Maggiolo, P Villani, et al.Giornale Italiano Di Medicina Del Lavoro|January 1, 1989
[Pathogenesis and clinical aspects of AIDS]R Maserati, L MinoliAIDS (London, England)|March 9, 2000
Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master GroupM Clerici, E Seminari, F Suter, et al.HIV Clinical Trials|October 24, 2001
Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 studyG Carosi, F Castelli, F Suter, et al.Giornale Italiano Di Medicina Del Lavoro|July 1, 1988
[Risks of AIDS among health personnel (physicians, nurses, obstetricians)]F Candura, G Moscato, R MaseratiChemotherapy|March 1, 1996
Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureusR Maserati, A E Cagni, C SegúGastrointestinal Radiology|January 1, 1992
Hepatic abscesses in immunocompromised patients: ultrasonically guided percutaneous drainageG Civardi, C Filice, M Caremani, et al.Pageof 28